Download AppThis is an educational overview, not medical advice. Do not change how you take any prescribed medication without talking to your clinician first.
There is a cruel twist buried in the way we treat headaches. The medicine that reliably ends today's attack can, if you reach for it too often, help set up tomorrow's. Clinicians call it medication-overuse headache. Most people know it by its older, blunter name: rebound.
It is common, it is easy to fall into without noticing, and it is one of the few kinds of chronic headache that often improves once you understand what is happening.
What rebound headache actually is
Formally, medication-overuse headache is a headache that shows up on 15 or more days a month, in someone who already has a headache disorder like migraine, and that developed while they were regularly overusing acute headache medication for more than three months (ICHD-3). "Acute" here means the drugs you take to stop an attack in progress, not the daily preventives meant to keep attacks away.
The pattern tends to creep. An attack comes, you treat it, the medicine works. Attacks come a little more often, so you treat a little more often. Over months the headaches quietly become more frequent and more constant, and the thing that once felt like the solution has become part of the machinery keeping them going.
The numbers that define "too often"
Not every pain reliever carries the same risk at the same frequency. The consensus thresholds, from the international headache classification, split roughly in two:
- Simple painkillers, meaning acetaminophen, aspirin, and other NSAIDs like ibuprofen, become a concern at 15 or more days a month (ICHD-3).
- Triptans, ergotamines, opioids, and combination pills (the ones that bundle a painkiller with caffeine or codeine) become a concern at 10 or more days a month (ICHD-3).
Worth being honest about one thing here. Those exact day counts come from expert consensus rather than clean trial evidence, and the classification itself says as much. They are a sensible line in the sand, not a biological cliff edge.
The practical version most clinicians give is simpler and more cautious. Try to keep any acute headache or migraine medication to no more than about two days a week (Mayo Clinic). That keeps you comfortably under every threshold above, whichever drug you use.
Who tends to fall into it
Rebound headache affects somewhere around 1 to 2 percent of adults worldwide, though estimates vary widely by country (review). It is markedly more common in women, by roughly three to one. And the single biggest risk factor is already having frequent migraine. In one large review, about 78 percent of people with medication-overuse headache had migraine underneath it (review, 2023).
That last point matters, because it points at some real uncertainty.
What we do not fully know
It is tempting to tell a tidy story where the pills simply cause the chronic headaches. The truth is less settled. Researchers still debate how much of this is the medication driving the worsening, and how much is that people with worsening headaches naturally take more medication because they hurt more often (debate paper). The underlying mechanism is not fully understood.
So the fair way to hold it is this. Cutting back on overused acute medication clearly helps many people, and that alone is reason enough to watch your medication days. But the arrow of cause and effect is not as clean as older explanations made it sound. What is not in doubt is how common this is among the people who hurt the most. More than half of everyone who has a headache on 15 or more days a month turns out to have medication overuse in the mix (ICHD-3).
The hopeful part
Here is the reason this is worth knowing at all. Rebound headache is one of the more reversible forms of chronic headache. The core treatment is unglamorous: with a clinician's guidance, cut back or stop the overused medication. Most people improve afterward, and their preventive treatments tend to start working better too (ICHD-3).
It is not painless. Headaches often get worse for the first several days to a couple of weeks before they get better, and some medications, opioids and butalbital especially, should only be tapered under medical supervision rather than stopped on your own (review, 2023). This is not a do it yourself project. But it is one of the few chronic pain situations where the path out is genuinely well mapped.
What this means for your tracking
You do not need to police yourself. You do need a number. The single figure worth knowing at any moment is how many days this month you have taken something to stop an attack. If that count keeps landing above two a week, that is your early signal, long before it ever becomes a diagnosis. Counting medication days is quiet and low effort, and it is exactly the kind of pattern that is easy to miss in the moment and obvious in hindsight.
If your acute medication is creeping upward, that is not a personal failing. It is one of the most common and most fixable traps in all of headache care. It is just worth catching early, and worth raising with your clinician rather than solving alone.
Sources for this piece include the ICHD-3 classification, the American Migraine Foundation, Mayo Clinic, and peer-reviewed reviews on epidemiology and treatment and current management.